Central Pharmaceutical JSC No. 3

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: VN000000DP36
VND
51,000.00
-300 (-0.58%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
Icon
Unrated Stock - No Analysis Available
stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

VND 1,102,947 Million (Small Cap)

stock-summary
P/E

9.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

5.85%

stock-summary
Debt Equity

-0.76

stock-summary
Return on Equity

24.20%

stock-summary
Price to Book

2.07

Revenue and Profits:
Net Sales:
94,244 Million
(Quarterly Results - Jun 2025)
Net Profit:
32,099 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-4.67%
0%
-4.67%
6 Months
-4.49%
0%
-4.49%
1 Year
-12.07%
0%
-12.07%
2 Years
-21.54%
0%
-21.54%
3 Years
41.67%
0%
41.67%
4 Years
12.83%
0%
12.83%
5 Years
53.61%
0%
53.61%

Central Pharmaceutical JSC No. 3 for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
1.60%
EBIT Growth (5y)
7.37%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.64
Sales to Capital Employed (avg)
0.88
Tax Ratio
20.24%
Dividend Payout Ratio
53.23%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
68.54%
ROE (avg)
26.75%
Valuation key factors
Factor
Value
P/E Ratio
9
Industry P/E
Price to Book Value
2.20
EV to EBIT
5.18
EV to EBITDA
4.90
EV to Capital Employed
5.90
EV to Sales
1.85
PEG Ratio
1.28
Dividend Yield
5.75%
ROCE (Latest)
113.87%
ROE (Latest)
24.96%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bearish
Dow Theory
Mildly Bullish
No Trend
OBV
Mildly Bearish
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is 2.55% vs -20.89% in Mar 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is 34.51% vs -52.36% in Mar 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "94,243.70",
          "val2": "91,902.20",
          "chgp": "2.55%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "32,194.90",
          "val2": "30,884.80",
          "chgp": "4.24%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "296.10",
          "val2": "64.80",
          "chgp": "356.94%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "32,099.20",
          "val2": "23,864.20",
          "chgp": "34.51%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "341.60%",
          "val2": "308.70%",
          "chgp": "3.29%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 1.89% vs -15.53% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is -3.27% vs 21.16% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "417,485.40",
          "val2": "409,730.80",
          "chgp": "1.89%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "149,130.80",
          "val2": "150,864.20",
          "chgp": "-1.15%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "161.50",
          "val2": "1,594.30",
          "chgp": "-89.87%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-605.10",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "121,171.60",
          "val2": "125,263.40",
          "chgp": "-3.27%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "327.40%",
          "val2": "334.10%",
          "chgp": "-0.67%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQstock-summary
Jun'25
Mar'25
Change(%)
Net Sales
94,243.70
91,902.20
2.55%
Operating Profit (PBDIT) excl Other Income
32,194.90
30,884.80
4.24%
Interest
296.10
64.80
356.94%
Exceptional Items
0.00
0.00
Consolidate Net Profit
32,099.20
23,864.20
34.51%
Operating Profit Margin (Excl OI)
341.60%
308.70%
3.29%
USD in Million.
Direction Arrows
Net Sales

QoQ Growth in quarter ended Jun 2025 is 2.55% vs -20.89% in Mar 2025

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Jun 2025 is 34.51% vs -52.36% in Mar 2025

Annual Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
417,485.40
409,730.80
1.89%
Operating Profit (PBDIT) excl Other Income
149,130.80
150,864.20
-1.15%
Interest
161.50
1,594.30
-89.87%
Exceptional Items
-605.10
0.00
Consolidate Net Profit
121,171.60
125,263.40
-3.27%
Operating Profit Margin (Excl OI)
327.40%
334.10%
-0.67%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2024 is 1.89% vs -15.53% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2024 is -3.27% vs 21.16% in Dec 2023

stock-summaryCompany CV
About Central Pharmaceutical JSC No. 3 stock-summary
stock-summary
Central Pharmaceutical JSC No. 3
Pharmaceuticals & Biotechnology
Central Pharmaceutical Joint Stock Company No3 (FORIPHARM) is a Vietnam-based company operating in the pharmaceutical industry, which is mainly engaged in the manufacture and trading of pharmaceutical products. The Company's leading products include botanical medicine and other types of drugs, health supplements and cosmetics, among others. Besides, the Company partakes in the commerce of medical equipment and supplies, as well as the conduct of medical research.
Company Coordinates stock-summary
Company Details
So 16 Le Dai Hanh, P. Minh Khai, Q. Hong Bang HAIPHONG None : None
stock-summary
Tel: 84 22 53842576
stock-summary
Registrar Details